P选择素与冠心病相关性的研究(2)
[2] Libby P, Ridker P, Maseri A. Inflammation and Atherosclerosis.Circulation, 2002, 105:1135-1143.
[3] Chyu KY, Shah PK. The role of inflammation in plaque disruption and thrombosis. Rev Cardiovasc Med, 2001, 2(2):82-91.
[4] Ross R.Atherosclerosis an inflammatory Disease. NEngl JMed, 1999, 340:115.
[5] Kamath S, Blamn AD, Caine GJ. Platelet P-selection levels in relation to plasma soluble P-selection and β-thromboglobulin levels in atrial fibrillation. Stoke, 2003, 33:1234-1242.
[6] Kinaly S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implication for therapy. Am J Cardiol, 1997, 80:111-161.
[7]水华.P-选择素在心血管疾病中的应用价值.心血管病杂志，2001， 22：165-167.
[8] Furman MI, Benoit SE, Bamard UR, et al. Increased platelet reactivity and circulating monolyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol, 1999,31:352-358.
[9] Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res, 2001, 89:763.
, http://www.100md.com(苏湘慈 苏湘利)
[3] Chyu KY, Shah PK. The role of inflammation in plaque disruption and thrombosis. Rev Cardiovasc Med, 2001, 2(2):82-91.
[4] Ross R.Atherosclerosis an inflammatory Disease. NEngl JMed, 1999, 340:115.
[5] Kamath S, Blamn AD, Caine GJ. Platelet P-selection levels in relation to plasma soluble P-selection and β-thromboglobulin levels in atrial fibrillation. Stoke, 2003, 33:1234-1242.
[6] Kinaly S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implication for therapy. Am J Cardiol, 1997, 80:111-161.
[7]水华.P-选择素在心血管疾病中的应用价值.心血管病杂志，2001， 22：165-167.
[8] Furman MI, Benoit SE, Bamard UR, et al. Increased platelet reactivity and circulating monolyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol, 1999,31:352-358.
[9] Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res, 2001, 89:763.
, http://www.100md.com(苏湘慈 苏湘利)